The potential of endurance exercise-derived exosomes to treat metabolic diseases

Nature Reviews Endocrinology

Volumn 12, Issue 9, 2016, Pages 504-517

  Safdar, Adeel ^a   Saleem, Ayesha ^a   Tarnopolsky, Mark A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APELIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CONNECTIVE TISSUE GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 21; FOLLISTATIN RELATED PROTEIN; GLUCAGON LIKE PEPTIDE 1; GROWTH DIFFERENTIATION FACTOR 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; IRISIN; LEUKEMIA INHIBITORY FACTOR; MICRORNA 1; MICRORNA 132; MICRORNA 192; MITOCHONDRIAL DNA; MYOSTATIN; SOMATOMEDIN C; VASCULOTROPIN A;

CYTOKINE RELEASE; ENDOSOME; ENDURANCE TRAINING; EXOSOME; HUMAN; INSULIN RESISTANCE; LYSOSOME; MEMBRANE MICROPARTICLE; METABOLIC DISORDER; MITOCHONDRIAL BIOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRECIPITATION; PRIORITY JOURNAL; PROKARYOTE; QUALITY OF LIFE; REVIEW; SIZE EXCLUSION CHROMATOGRAPHY; SKELETAL MUSCLE; ULTRACENTRIFUGATION; ANIMAL; DIABETES MELLITUS, TYPE 2; ENDURANCE; EXERCISE; METABOLIC DISEASES; METABOLISM; PHYSIOLOGY; TRANSPLANTATION;

ANIMALS; DIABETES MELLITUS, TYPE 2; EXERCISE; EXOSOMES; EXTRACELLULAR VESICLES; HUMANS; METABOLIC DISEASES; MUSCLE, SKELETAL; OBESITY; PHYSICAL ENDURANCE;

EID: 84969963050     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2016.76     Document Type: Review

References (199)

1. Bramble, D. M. & Lieberman, D. E. Endurance running and the evolution of Homo. Nature 432, 345-352 (2004).
2. Pedersen, B. K. & Febbraio, M. A. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8, 457-465 (2012).
3. Steensberg, A. et al. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J. Physiol. 537, 633-639 (2001).
4. Thery, C., Zitvogel, L. & Amigorena, S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569-579 (2002).
5. Choi, D. S., Kim, D. K., Kim, Y. K. & Gho, Y. S. Proteomics of extracellular vesicles: exosomes and ectosomes. Mass Spectrom. Rev. 34, 474-490 (2015).
6. Hagiwara, K., Ochiya, T. & Kosaka, N. A paradigm shift for extracellular vesicles as small RNA carriers: from cellular waste elimination to therapeutic applications. Drug Delivery Transl Res. 4, 31-37 (2014).
7. Januszyk, K. & Lima, C. D. The eukaryotic RNA exosome. Curr. Opin. Struct. Biol. 24, 132-140 (2014).
8. Barutta, F. et al. Urinary exosomal microRNAs in incipient diabetic nephropathy. PLoS ONE 8, e73798 (2013).
9. Korc, M. Pancreatic cancer-associated diabetes is an 'exosomopathy'. Clin. Cancer Res. 21, 1508-1510 (2015).
10. Kranendonk, M. E. et al. Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease. Cardiovasc. Diabetol. 13, 37 (2014).
11. Yanez-Mo, M. et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles 4, 27066 (2015).
12. Rahman, M. J., Regn, D., Bashratyan, R. & Dai, Y. D. Exosomes released by islet-derived mesenchymal stem cells trigger autoimmune responses in NOD mice. Diabetes 63, 1008-1020 (2014).
13. Zubiri, I. et al. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis. J. Proteomics 96, 92-102 (2014).
14. Mendis, S., Davis, S. & Norrving, B. Organizational update: The world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke 46, e121-e122 (2015).
15. Katzmarzyk, P. T., Gledhill, N. & Shephard, R. J. The economic burden of physical inactivity in Canada. CMAJ 163, 1435-1440 (2000).
16. Katzmarzyk, P. T. & Janssen, I. The economic costs associated with physical inactivity and obesity in Canada: An update. Can. J. Appl. Physiol. 29, 90-115 (2004).
17. Chakravarty, E. F., Hubert, H. B., Lingala, V. B. & Fries, J. F. Reduced disability and mortality among aging runners: A 21-year longitudinal study. Arch. Intern. Med. 168, 1638-1164 (2008).
18. Woodcock, J., Franco, O. H., Orsini, N. & Roberts, I. Non-vigorous physical activity and all-cause mortality: systematic review and meta-analysis of cohort studies. Int. J. Epidemiol. 40, 121-138 (2011).
19. Avery, L., Flynn, D., van Wersch, A., Sniehotta, F. F. & Trenell, M. I. Changing physical activity behavior in type 2 diabetes: A systematic review and meta-analysis of behavioral interventions. Diabetes Care 35, 2681-2689 (2012).
20. Helmrich, S. P., Ragland, D. R., Leung, R. W. & Paffenbarger, R. S. Jr. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 325, 147-152 (1991).
21. American Association of Diabetes Educators. Diabetes and physical activity. Diabetes Educ. 38, 129-132 (2012).
22. Knowler, W. C. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393-403 (2002).
23. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374, 1677-1686 (2009).
24. Hawley, J. A. Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance. Diabetes Metab. Res. Rev. 20, 383-393 (2004).
25. Morino, K., Petersen, K. F. & Shulman, G. I. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55, S9-S15 (2006).
26. Joseph, A. M. & Hood, D. A. Relationships between exercise, mitochondrial biogenesis and type 2 diabetes. Med. Sport Sci. 60, 48-61 (2014).
27. Morino, K. et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest. 115, 3587-3593 (2005).
28. Ritov, V. B. et al. Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am. J. Physiol. Endocrinol. Metab. 298, E49-E58 (2010).
29. Simoneau, J. A., Colberg, S. R., Thaete, F. L. & Kelley, D. E. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J. 9, 273-278 (1995).
30. Lowell, B. B. & Shulman, G. I. Mitochondrial dysfunction and type 2 diabetes. Science 307, 384-387 (2005).
31. Petersen, K. F. & Shulman, G. I. Etiology of insulin resistance. Am. J. Med. 119, S10-16 (2006).
32. Dela, F. et al. Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes 43, 862-865 (1994).
33. Greiwe, J. S., Holloszy, J. O. & Semenkovich, C. F. Exercise induces lipoprotein lipase and GLUT-4 protein in muscle independent of adrenergic-receptor signaling. J. Appl. Physiol. 89, 176-181 (2000).
34. Gulve, E. A. & Spina, R. J. Effect of 7-10 days of cycle ergometer exercise on skeletal muscle GLUT-4 protein content. J. Appl. Physiol. 79, 1562-1566 (1995).
35. Phillips, S. M., Han, X. X., Green, H. J. & Bonen, A. Increments in skeletal muscle GLUT-1 and GLUT-4 after endurance training in humans. Am. J. Physiol. 270, E456-E462 (1996).
36. Ren, J. M., Semenkovich, C. F., Gulve, E. A., Gao, J. & Holloszy, J. O. Exercise induces rapid increases in GLUT4 expression, glucose transport capacity, and insulin-stimulated glycogen storage in muscle. J. Biol. Chem. 269, 14396-14401 (1994).
37. Langin, D. Recruitment of brown fat and conversion of white into brown adipocytes: strategies to fight the metabolic complications of obesity? Biochim. Biophys. Acta 1801, 372-376 (2010).
38. Lo, K. A. & Sun, L. Turning WAT into BAT: A review on regulators controlling the browning of white adipocytes. Biosci. Rep. 33, e00065 (2013).
39. Bostrom, P. et al. A PGC1-?-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463-468 (2012).
40. Kajimura, S., Spiegelman, B. M. & Seale, P. Brown and beige fat: physiological roles beyond heat generation. Cell Metab. 22, 546-559 (2015).
41. Sidossis, L. S. et al. Browning of subcutaneous white adipose tissue in humans after severe adrenergic stress. Cell Metab. 22, 219-227 (2015).
42. Albrecht, E. et al. Irisin - a myth rather than an exercise-inducible myokine. Sci. Rep. 5, 8889 (2015).
43. Rao, R. R. et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 157, 1279-1291 (2014).
44. Lee, P. et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 19, 302-309 (2014).
45. Patsouris, D. et al. Burn induces browning of the subcutaneous white adipose tissue in mice and humans. Cell Rep. 13, 1538-1544 (2015).
46. Boveris, A. & Navarro, A. Systemic and mitochondrial adaptive responses to moderate exercise in rodents. Free Radic. Biol. Med. 44, 224-229 (2008).
47. Safdar, A. et al. Endurance exercise rescues progeroid aging and induces systemic mitochondrial rejuvenation in mtDNA mutator mice. Proc. Natl Acad. Sci. USA 108, 4135-4140 (2011).
48. Sutherland, L. N., Bomhof, M. R., Capozzi, L. C., Basaraba, S. A. & Wright, D. C. Exercise and adrenaline increase PGC-1? mRNA expression in rat adipose tissue. J. Physiol. 587, 1607-1617 (2009).
49. Clark-Matott, J. et al. Metabolomic analysis of exercise effects in the POLG mitochondrial DNA mutator mouse brain. Neurobiol. Aging 36, 2972-2983 (2015).
50. Cameron, I., Alam, M. A., Wang, J. & Brown, L. Endurance exercise in a rat model of metabolic syndrome. Can. J. Physiol. Pharmacol. 90, 1490-1497 (2012).
51. Devries, M. C. et al. Endurance training modulates intramyocellular lipid compartmentalization and morphology in skeletal muscle of lean and obese women. J. Clin. Endocrinol. Metab. 98, 4852-4862 (2013).
52. Devries, M. C. et al. Endurance training without weight loss lowers systemic, but not muscle, oxidative stress with no effect on inflammation in lean and obese women. Free Radic. Biol. Med. 45, 503-511 (2008).
53. Dutheil, F. et al. Different modalities of exercise to reduce visceral fat mass and cardiovascular risk in metabolic syndrome: The RESOLVE randomized trial. Int. J. Cardiol. 168, 3634-3642 (2013).
54. Lalande, S., Petrella, R. J. & Shoemaker, J. K. Effect of exercise training on diastolic function in metabolic syndrome. Appl. Physiol. Nutr. Metab. 38, 545-550 (2013).
55. Landaeta-Diaz, L. et al. Mediterranean diet, moderate-to-high intensity training, and health-related quality of life in adults with metabolic syndrome. Eur. J. Prev. Cardiol. 20, 555-564 (2013).
56. Peters, S. J. et al. Perilipin family (PLIN) proteins in human skeletal muscle: The effect of sex, obesity, and endurance training. Appl. Physiol. Nutr. Metab. 37, 724-735 (2012).
57. Samjoo, I. A. et al. Markers of skeletal muscle mitochondrial function and lipid accumulation are moderately associated with the homeostasis model assessment index of insulin resistance in obese men. PLoS ONE 8, e66322 (2013).
58. Samjoo, I. A., Safdar, A., Hamadeh, M. J., Raha, S. & Tarnopolsky, M. A. The effect of endurance exercise on both skeletal muscle and systemic oxidative stress in previously sedentary obese men. Nutr. Diabetes 3, e88 (2013).
59. Mahoney, D. J., Parise, G., Melov, S., Safdar, A. & Tarnopolsky, M. A. Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J. 19, 1498-1500 (2005).
60. Hawley, J. A., Hargreaves, M., Joyner, M. J. & Zierath, J. R. Integrative biology of exercise. Cell 159, 738-749 (2014).
61. Warburton, D. E., Charlesworth, S., Ivey, A., Nettlefold, L. & Bredin, S. S. A systematic review of the evidence for Canada's Physical Activity Guidelines for Adults. Int. J. Behav. Nutr. Phys. Act. 7, 39 (2010).
62. Stuart, M., Chard, S., Benvenuti, F. & Steinwachs, S. Community exercise: A vital component to healthy aging. Healthc. Pap. 10, 23-28; discussion 79-83 (2009).
63. Kruk, J. Physical activity and health. Asian Pac. J. Cancer Prev. 10, 721-728 (2009).
64. Crane, J. D. et al. Exercise-stimulated interleukin-15 is controlled by AMPK and regulates skin metabolism and aging. Aging Cell 14, 625-634 (2015).
65. Balbuena, L. & Casson, A. G. Physical activity, obesity and risk for esophageal adenocarcinoma. Future Oncol. 5, 1051-1063 (2009).
66. Brenner, I. Exercise performance by hemodialysis patients: A review of the literature. Physician Sportsmed. 37, 84-96 (2009).
67. Buchner, D. M. Physical activity and prevention of cardiovascular disease in older adults. Clin. Geriatr. Med. 25, 661-675, viii (2009).
68. Stessman, J., Hammerman-Rozenberg, R., Cohen, A., Ein-Mor, E. & Jacobs, J. M. Physical activity, function, and longevity among the very old. Arch. Intern. Med. 169, 1476-1483 (2009).
69. Little, J. P., Safdar, A., Benton, C. R. & Wright, D. C. Skeletal muscle and beyond: The role of exercise as a mediator of systemic mitochondrial biogenesis. Appl. Physiol. Nutr. Metab. 36, 598-607 (2011).
70. Pedersen, B. K. The diseasome of physical inactivity - and the role of myokines in muscle-fat cross talk. J. Physiol. 587, 5559-5568 (2009).
71. Pedersen, B. K. Edward, F. Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. J. Appl. Physiol. 107, 1006-1014 (2009).
72. Pedersen, B. K. Muscles and their myokines. J. Exp. Biol. 214, 337-346 (2011).
73. Pedersen, L. & Hojman, P. Muscle-to-organ cross talk mediated by myokines. Adipocyte 1, 164-167 (2012).
74. Li, Z. Y. et al. Subfatin is a novel adipokine and unlike Meteorin in adipose and brain expression. CNS Neurosci. Ther. 20, 344-354 (2014).
75. Lombardi, G., Sanchis-Gomar, F., Perego, S., Sansoni, V. & Banfi, G. Implications of exercise-induced adipo-myokines in bone metabolism. Endocrine http://dx. doi. org/10. 1007/s12020-015-0834-0 (2015).
76. Little, J. P. & Safdar, A. Adipose-brain crosstalk: do adipokines have a role in neuroprotection? Neural Regen. Res. 10, 1381-1382 (2015).
77. Gorgens, S. W., Eckardt, K., Jensen, J., Drevon, C. A. & Eckel, J. Exercise and regulation of adipokine and myokine production. Prog. Mol. Biol. Transl Sci. 135, 313-336 (2015).
78. Iroz, A., Couty, J. P. & Postic, C. Hepatokines: unlocking the multi-organ network in metabolic diseases. Diabetologia 58, 1699-1703 (2015).
79. Pedersen, B. K. et al. The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor? Proc. Nutr. Soc. 63, 263-267 (2004).
80. Pedersen, B. K. IL-6 signalling in exercise and disease. Biochem. Soc. Trans. 35, 1295-1297 (2007).
81. Pedersen, B. K. & Fischer, C. P. Physiological roles of muscle-derived interleukin-6 in response to exercise. Curr. Opin. Clin. Nutr. Metab. Care 10, 265-271 (2007).
82. Pedersen, B. K. & Fischer, C. P. Beneficial health effects of exercise - the role of IL-6 as a myokine. Trends Pharmacol. Sci. 28, 152-156 (2007).
83. Wallenius, V. et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 8, 75-79 (2002).
84. Ellingsgaard, H. et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and ? Cells. Nat. Med. 17, 1481-1489 (2011).
85. Seldin, M. M. et al. Skeletal muscle-derived myonectin activates the mammalian target of rapamycin (mTOR) pathway to suppress autophagy in liver. J. Biol. Chem. 288, 36073-36082 (2013).
86. Seldin, M. M., Peterson, J. M., Byerly, M. S., Wei, Z. & Wong, G. W. Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. J. Biol. Chem. 287, 11968-11980 (2012).
87. Florholmen, G. et al. Leukaemia inhibitory factor stimulates glucose transport in isolated cardiomyocytes and induces insulin resistance after chronic exposure. Diabetologia 49, 724-731 (2006).
88. Matthews, V. B. et al. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia 52, 1409-1418 (2009).
89. Kim, K. H. et al. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat. Med. 19, 83-92 (2013).
90. Xu, J. et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58, 250-259 (2009).
91. Hansen, J. S. et al. Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans. Mol. Metab. 4, 551-560 (2015).
92. Choi, S. B., Jang, J. S., Hong, S. M., Jun, D. W. & Park, S. Exercise and dexamethasone oppositely modulate ?-cell function and survival via independent pathways in 90% pancreatectomized rats. J. Endocrinol. 190, 471-482 (2006).
93. Gregory, S. M. et al. Exercise-induced insulin-like growth factor I system concentrations after training in women. Med. Sci. Sports Exerc. 45, 420-428 (2013).
94. Mohajeri Tehrani, M. R., Tajvidi, M., Kahrizi, S. & Hedayati, M. Does endurance training affect IGF-1/ IGFBP-3 and insulin sensitivity in patients with type 2 diabetes? J. Sports Med. Phys. Fitness 55, 1004-1012 (2015).
95. Lickert, H. Betatrophin fuels ? Cell proliferation: first step toward regenerative therapy? Cell Metab. 18, 5-6 (2013).
96. Yi, P., Park, J. S. & Melton, D. A. Betatrophin: A hormone that controls pancreatic ? Cell proliferation. Cell 153, 747-758 (2013).
97. Gusarova, V. et al. ANGPTL8/betatrophin does not control pancreatic ? Cell expansion. Cell 159, 691-696 (2014).
98. Abu-Farha, M. et al. Lack of associations between betatrophin/ANGPTL8 level and C-peptide in type 2 diabetic subjects. Cardiovasc. Diabetol. 14, 112 (2015).
99. Wang, L. et al. Circulating levels of betatrophin and irisin are not associated with pancreatic ?-cell function in previously diagnosed type 2 diabetes mellitus patients. J. Diabetes Res. 2016, 2616539 (2016).
100. Abu-Farha, M. et al. Circulating ANGPTL8/betatrophin is increased in obesity and reduced after exercise training. PLoS ONE 11, e0147367 (2016).
101. Adlakha, Y. K. & Saini, N. Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. Mol. Cancer 13, 33 (2014).
102. Barreiro, E. & Sznajder, J. I. Epigenetic regulation of muscle phenotype and adaptation: A potential role in COPD muscle dysfunction. J. Appl. Physiol. 114, 1263-1272 (2013).
103. Chen, Y. & Verfaillie, C. M. MicroRNAs: The fine modulators of liver development and function. Liver Int. 34, 976-990 (2014).
104. Fernandez-Hernando, C. & Baldan, A. MicroRNAs and cardiovascular disease. Curr. Genet. Med. Rep. 1, 30-38 (2013).
105. Kuppusamy, K. T., Sperber, H. & Ruohola-Baker, H. MicroRNA regulation and role in stem cell maintenance, cardiac differentiation and hypertrophy. Curr. Mol. Med. 13, 757-764 (2013).
106. Tani, S., Kuraku, S., Sakamoto, H., Inoue, K. & Kusakabe, R. Developmental expression and evolution of muscle-specific microRNAs conserved in vertebrates. Evol. Dev. 15, 293-304 (2013).
107. Trounson, A. A rapidly evolving revolution in stem cell biology and medicine. Reprod. Biomed. Online 27, 756-764 (2013).
108. Romao, J. M., Jin, W., He, M., McAllister, T. & Guan, L. L. MicroRNAs in bovine adipogenesis: genomic context, expression and function. BMC Genomics 15, 137 (2014).
109. Aoi, W. et al. The microRNA miR-696 regulates PGC-1? in mouse skeletal muscle in response to physical activity. Am. J. Physiol. Endocrinol. Metab. 298, E799-E806 (2010).
110. Hoppeler, H., Baum, O., Lurman, G. & Mueller, M. Molecular mechanisms of muscle plasticity with exercise. Compr. Physiol. 1, 1383-1412 (2011).
111. Mooren, F. C., Viereck, J., Kruger, K. & Thum, T. Circulating microRNAs as potential biomarkers of aerobic exercise capacity. Am. J. Physiol. Heart Circulatory Physiol. 306, H557-H563 (2014).
112. Nielsen, S. et al. Muscle specific miRNAs are induced by testosterone and independently upregulated by age. Front. Physiol. 4, 394 (2013).
113. Nielsen, S. et al. Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle. J. Physiol. 588, 4029-4037 (2010).
114. Ooi, J. Y., Bernardo, B. C. & McMullen, J. R. The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy. Future Med. Chem. 6, 205-222 (2014).
115. Russell, A. P. et al. Regulation of miRNAs in human skeletal muscle following acute endurance exercise and short-term endurance training. J. Physiol. 591, 4637-4653 (2013).
116. Safdar, A., Abadi, A., Akhtar, M., Hettinga, B. P. & Tarnopolsky, M. A. miRNA in the regulation of skeletal muscle adaptation to acute endurance exercise in C57Bl/6J male mice. PLoS ONE 4, e5610 (2009).
117. Timmons, J. A. Modulation of microRNAs during exercise and disease in human skeletal muscle. Exerc. Sport Sci. Rev. 39, 218; author reply 219 (2011).
118. Granjon, A. et al. The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/ myocyte enhancer factor 2C pathway. Diabetes 58, 2555-2564 (2009).
119. Parrizas, M. et al. Circulating miR-192 and miR-193b are markers of prediabetes and are modulated by an exercise intervention. J. Clin. Endocrinol. Metab. 100, E407-E415 (2015).
120. Filios, S. R. & Shalev, A. ?-cell microRNAs: small but powerful. Diabetes 64, 3631-3644 (2015).
121. Nesca, V. et al. Identification of particular groups of microRNAs that positively or negatively impact on ? Cell function in obese models of type 2 diabetes. Diabetologia 56, 2203-2212 (2013).
122. Nielsen, S. et al. The miRNA plasma signature in response to acute aerobic exercise and endurance training. PLoS ONE 9, e87308 (2014).
123. Radom-Aizik, S. et al. Effects of exercise on microRNA expression in young males peripheral blood mononuclear cells. Clin. Transl Sci. 5, 32-38 (2012).
124. Guay, C., Menoud, V., Rome, S. & Regazzi, R. Horizontal transfer of exosomal microRNAs transduce apoptotic signals between pancreatic ?-cells. Cell Commun. Signal. 13, 17 (2015).
125. McLean, C. S. et al. Gene and microRNA expression responses to exercise; relationship with insulin sensitivity. PLoS ONE 10, e0127089 (2015).
126. Mootha, V. K. et al. PGC-1?-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267-273 (2003).
127. Pilegaard, H., Saltin, B. & Neufer, P. D. Exercise induces transient transcriptional activation of the PGC-1? gene in human skeletal muscle. J. Physiol. 546, 851-858 (2003).
128. Safdar, A. et al. Exercise increases mitochondrial PGC-1? Content and promotes nuclear-mitochondrial cross-talk to coordinate mitochondrial biogenesis. J. Biol. Chem. 286, 10605-10617 (2011).
129. Lin, J. et al. PGC-1? in the regulation of hepatic glucose and energy metabolism. J. Biol. Chem. 278, 30843-30848 (2003).
130. Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839 (1998).
131. Sawada, N. et al. Endothelial PGC-1? mediates vascular dysfunction in diabetes. Cell Metab. 19, 246-258 (2014).
132. Allen, J. et al. High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat. Biotechnol. 21, 692-696 (2003).
133. An, J. et al. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat. Med. 10, 268-274 (2004).
134. Nicholson, J. K. & Wilson, I. D. Understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. 2, 668-676 (2003).
135. Raamsdonk, L. M. et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat. Biotechnol. 19, 45-50 (2001).
136. Lewis, G. D. et al. Metabolic signatures of exercise in human plasma. Sci. Transl Med. 2, 33ra37 (2010).
137. Muhsen Ali, A. et al. Metabolomic profiling of submaximal exercise at a standardised relative intensity in healthy adults. Metabolites 6, 9 (2016).
138. Van Hall, G. et al. Leg and arm lactate and substrate kinetics during exercise. Am. J. Physiol. Endocrinol. Metab. 284, E193-E205 (2003).
139. Sahlin, K., Katz, A. & Broberg, S. Tricarboxylic acid cycle intermediates in human muscle during prolonged exercise. Am. J. Physiol. 259, C834-C841 (1990).
140. Henriksson, J. Effect of exercise on amino acid concentrations in skeletal muscle and plasma. J. Exp. Biol. 160, 149-165 (1991).
141. Gibala, M. J., MacLean, D. A., Graham, T. E. & Saltin, B. Tricarboxylic acid cycle intermediate pool size and estimated cycle flux in human muscle during exercise. Am. J. Physiol. 275, E235-E242 (1998).
142. Eriksson, L. S., Broberg, S., Bjorkman, O. & Wahren, J. Ammonia metabolism during exercise in man. Clin. Physiol. 5, 325-336 (1985).
143. Jang, C. et al. A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat. Med. 22, 421-426 (2016).
144. Sahlin, K., Gorski, J. & Edstrom, L. Influence of ATP turnover and metabolite changes on IMP formation and glycolysis in rat skeletal muscle. Am. J. Physiol. 259, C409-C412 (1990).
145. Sapieha, P. et al. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat. Med. 14, 1067-1076 (2008).
146. He, W. et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429, 188-193 (2004).
147. Carriere, A. et al. Browning of white adipose cells by intermediate metabolites: An adaptive mechanism to alleviate redox pressure. Diabetes 63, 3253-3265 (2014).
148. Deatherage, B. L. & Cookson, B. T. Membrane vesicle release in bacteria, eukaryotes, and archaea: A conserved yet underappreciated aspect of microbial life. Infect. Immun. 80, 1948-1957 (2012).
149. Kulp, A. & Kuehn, M. J. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu. Rev. Microbiol. 64, 163-184 (2010).
150. McBroom, A. J., Johnson, A. P., Vemulapalli, S. & Kuehn, M. J. Outer membrane vesicle production by Escherichia coli is independent of membrane instability. J. Bacteriol. 188, 5385-5392 (2006).
151. Lee, E. Y. et al. Gram-positive bacteria produce membrane vesicles: proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles. Proteomics 9, 5425-5436 (2009).
152. Rivera, J. et al. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Proc. Natl Acad. Sci. USA 107, 19002-19007 (2010).
153. Ellen, A. F. et al. Proteomic analysis of secreted membrane vesicles of archaeal Sulfolobus species reveals the presence of endosome sorting complex components. Extremophiles 13, 67-79 (2009).
154. Rachel, R., Wyschkony, I., Riehl, S. & Huber, H. The ultrastructure of Ignicoccus: evidence for a novel outer membrane and for intracellular vesicle budding in an archaeon. Archaea 1, 9-18 (2002).
155. Sugiura, A., McLelland, G. L., Fon, E. A. & McBride, H. M. A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J. 33, 2142-2156 (2014).
156. Andrade-Navarro, M. A., Sanchez-Pulido, L. & McBride, H. M. Mitochondrial vesicles: An ancient process providing new links to peroxisomes. Curr. Opin. Cell Biol. 21, 560-567 (2009).
157. Soubannier, V. et al. A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. Curr. Biol. 22, 135-141 (2012).
158. McLelland, G. L., Soubannier, V., Chen, C. X., McBride, H. M. & Fon, E. A. Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J. 33, 282-295 (2014).
159. Esquilin, Y., Queenan, C., Calabri, A. & Leonardi, D. mtDNA migration and the role of exosomes in horizontal gene transfer. Microsc. Microanal. 18, 286-287 (2012).
160. Pan, B. T. & Johnstone, R. M. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33, 967-978 (1983).
161. Hwang, I. Cell-cell communication via extracellular membrane vesicles and its role in the immune response. Mol. Cells 36, 105-111 (2013).
162. Kalani, A., Tyagi, A. & Tyagi, N. Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics. Mol. Neurobiol. 49, 590-600 (2014).
163. Record, M., Carayon, K., Poirot, M. & Silvente-Poirot, S. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim. Biophys. Acta 1841, 108-120 (2014).
164. Colombo, M., Raposo, G. & Thery, C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30, 255-289 (2014).
165. Raposo, G. & Stoorvogel, W. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200, 373-383 (2013).
166. Mathivanan, S., Ji, H. & Simpson, R. J. Exosomes: extracellular organelles important in intercellular communication. J. Proteomics 73, 1907-1920 (2010).
167. Urbanelli, L. et al. Signaling pathways in exosomes biogenesis, secretion and fate. Genes 4, 152-170 (2013).
168. Stuffers, S., Sem Wegner, C., Stenmark, H. & Brech, A. Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic 10, 925-937 (2009).
169. Bianco, F. et al. Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 28, 1043-1054 (2009).
170. Lachenal, G. et al. Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol. Cell. Neurosci. 46, 409-418 (2011).
171. Savina, A., Fader, C. M., Damiani, M. T. & Colombo, M. I. Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic 6, 131-143 (2005).
172. Skokos, D. et al. Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J. Immunol. 170, 3037-3045 (2003).
173. Andre, F. et al. Tumor-derived exosomes: A new source of tumor rejection antigens. Vaccine 20 (Suppl. 4), A28-A31 (2002).
174. Aucher, A., Rudnicka, D. & Davis, D. M. MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation. J. Immunol. 191, 6250-6260 (2013).
175. Pope, S. M. & Lasser, C. Toxoplasma gondii infection of fibroblasts causes the production of exosome-like vesicles containing a unique array of mRNA and miRNA transcripts compared to serum starvation. J. Extracell. Vesicles 2, http://dx. doi. org/10. 3402/jev. v2i0. 22484 (2013).
176. Ramakrishnaiah, V. et al. Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7. 5 cells. Proc. Natl Acad. Sci. USA 110, 13109-13113 (2013).
177. Wolfers, J. et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7, 297-303 (2001).
178. Mathivanan, S. & Simpson, R. J. ExoCarta: A compendium of exosomal proteins and RNA. Proteomics 9, 4997-5000 (2009).
179. Booth, A. M. et al. Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J. Cell Biol. 172, 923-935 (2006).
180. El-Andaloussi, S. et al. Exosome-mediated delivery of siRNA in vitro and in vivo. Nat. Protoc. 7, 2112-2126 (2012).
181. Lotvall, J. et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: A position statement from the International Society for Extracellular Vesicles. J. Extracell. Vesicles 3, 26913 (2014).
182. Aswad, H. et al. Exosomes participate in the alteration of muscle homeostasis during lipid-induced insulin resistance in mice. Diabetologia 57, 2155-2164 (2014).
183. Hood, D. A. Invited review: contractile activity-induced mitochondrial biogenesis in skeletal muscle. J. Appl. Physiol. 90, 1137-1157 (2001).
184. Forterre, A. et al. Proteomic analysis of C2C12 myoblast and myotube exosome-like vesicles: A new paradigm for myoblast-myotube cross talk? PLoS ONE 9, e84153 (2014).
185. Ojimaa, K. O. et al. Proteomic analysis of secreted proteins from skeletal muscle cells during differentiation. EuPA Open Proteom. 5, 1-9 (2014).
186. Fruhbeis, C., Helmig, S., Tug, S., Simon, P. & Kramer-Albers, E. M. Physical exercise induces rapid release of small extracellular vesicles into the circulation. J. Extracell. Vesicles 4, 28239 (2015).
187. Helmig, S., Fruhbeis, C., Kramer-Albers, E. M., Simon, P. & Tug, S. Release of bulk cell free DNA during physical exercise occurs independent of extracellular vesicles. Eur. J. Appl. Physiol. 115, 2271-2280 (2015).
188. Sahoo, S. et al. Exosomes from human CD34+ stem cells mediate their proangiogenic paracrine activity. Circ. Res. 109, 724-728 (2011).
189. Lansford, K. A. et al. Effect of acute exercise on circulating angiogenic cell and microparticle populations. Exp. Physiol. 101, 155-167 (2015).
190. Harris, E., Rakobowchuk, M. & Birch, K. M. Sprint interval and sprint continuous training increases circulating CD34+ cells and cardio-respiratory fitness in young healthy women. PLoS ONE 9, e108720 (2014).
191. Chaturvedi, P., Kalani, A., Medina, I., Familtseva, A. & Tyagi, S. C. Cardiosome mediated regulation of MMP9 in diabetic heart: role of mir29b and mir455 in exercise. J. Cell. Mol. Med. 19, 2153-2161 (2015).
192. Wiklander, O. P. et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J. Extracell. Vesicles 4, 26316 (2015).
193. Garcia, N. A., Moncayo-Arlandi, J., Sepulveda, P. & Diez-Juan, A. Cardiomyocyte exosomes regulate glycolytic flux in endothelium by direct transfer of GLUT transporters and glycolytic enzymes. Cardiovasc. Res. 109, 397-408 (2016).
194. Sokolova, V. et al. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf. B Biointerfaces 87, 146-150 (2011).
195. Soekmadji, C., Russell, P. J. & Nelson, C. C. Exosomes in prostate cancer: putting together the pieces of a puzzle. Cancers (Basel) 5, 1522-1544 (2013).
196. Little, J. P., Safdar, A., Bishop, D., Tarnopolsky, M. A. & Gibala, M. J. An acute bout of high-intensity interval training increases the nuclear abundance of PGC-1? and activates mitochondrial biogenesis in human skeletal muscle. Am. J. Physiol. Reg. Integr. Comp. Physiol. 300, R1303-R1310 (2011).
197. Earnest, C. P. et al. Interval training in men at risk for insulin resistance. Int. J. Sports Med. 34, 355-363 (2013).
198. Tarnopolsky, M. et al. Creatine monohydrate and conjugated linoleic acid improve strength and body composition following resistance exercise in older adults. PLoS ONE 2, e991 (2007).
199. National Institutes of Health. Molecular transducers of physical activity in humans. https://commonfund. nih. gov/MolecularTransducers (2016).